KURA icon

Kura Oncology

133 hedge funds and large institutions have $687M invested in Kura Oncology in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 64 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

63% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 24

77% less call options, than puts

Call options by funds: $201K | Put options by funds: $892K

Holders
133
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$201K
Puts
$892K
Net Calls
Net Calls Change

Top Buyers

1 +$10.4M
2 +$6.96M
3 +$5.37M
4
SCM
Suvretta Capital Management
New York
+$2.8M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.51M

Top Sellers

1 -$9.17M
2 -$6.66M
3 -$5.29M
4
EP
Eversept Partners
New York
-$4.77M
5
Goldman Sachs
Goldman Sachs
New York
-$4.28M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$118K
102
$109K
103
$108K
104
$103K
105
$101K
106
$96.5K
107
$96.5K
108
$95.8K
109
$91.7K
110
$87.5K
111
$82.1K
112
$78.7K
113
$62K
114
$59.1K
115
$37.6K
116
$32.7K
117
$32.6K
118
$26K
119
$17.3K
120
$13.2K
121
$8.88K
122
$4K
123
$3.28K
124
$3.19K
125
$2K